NASDAQ:ALZN

Alzamend Neuro Stock Insider Trading

Healthcare > Biotechnology

Buy ALZN

*Your capital is at risk

$1.15

+0.0100 (+0.88%)

At Close: Jun 03, 2026

Alzamend Neuro Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -92.04. In total, the insiders bought 1.99M and sold 1.82M ALZN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-92.04
● Buy	1.99M shares
● Sell	1.82M shares
31% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Apr 14, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -92.04. Confidence increased due to high data reliability score of 90.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 14, 2026 Buy	Common Stock P-Purchase	Ault Milton C Iii Director	Director	108 388 Value: $108.9K
Dec 23, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	1 851 Value: $4K
Dec 19, 2025 Sell	Common Stock S-Sale	Horne William B. Director	Director	3 333 Value: $7K
Oct 23, 2025 Sell	Common Stock S-Sale	Mcgrath Lynne Fahey Director	Director	30 Value: $69
Oct 09, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	20 397 Value: $47.4K
Oct 09, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	20 397 Value: $47.4K
Oct 08, 2025 Sell	Series B Convertible Preferred Stock C-Conversion	Ault Milton C Iii Director	Director	143 Value: $332
Oct 08, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	101 394 Value: $247.2K
Oct 08, 2025 Buy	Common Stock C-Conversion	Ault Milton C Iii Director	Director	61 743 Value: $143.2K
Oct 08, 2025 Sell	Series B Convertible Preferred Stock C-Conversion	Ault Milton C Iii Director	Director	143 Value: $332
Oct 08, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	101 394 Value: $247.2K
Oct 08, 2025 Buy	Common Stock C-Conversion	Ault Milton C Iii Director	Director	61 743 Value: $143.2K
Oct 07, 2025 Buy	Common Stock C-Conversion	Ault Milton C Iii Director	Director	100 000 Value: $232.0K
Oct 07, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	57 379 Value: $143.0K
Oct 07, 2025 Sell	Series B Convertible Preferred Stock C-Conversion	Ault Milton C Iii Director	Director	232 Value: $538
Oct 07, 2025 Sell	Series B Convertible Preferred Stock C-Conversion	Ault Milton C Iii Director	Director	232 Value: $538
Oct 07, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	57 379 Value: $143.0K
Oct 07, 2025 Buy	Common Stock C-Conversion	Ault Milton C Iii Director	Director	100 000 Value: $232.0K
Oct 06, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	82 033 Value: $201.3K
Oct 06, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	82 033 Value: $201.3K
Oct 03, 2025 Buy	Common Stock C-Conversion	Ault Milton C Iii Director	Director	100 000 Value: $232.0K
Oct 03, 2025 Sell	Series B Convertible Preferred Stock C-Conversion	Ault Milton C Iii Director	Director	232 Value: $538
Oct 03, 2025 Sell	Series B Convertible Preferred Stock C-Conversion	Ault Milton C Iii Director	Director	232 Value: $538
Oct 03, 2025 Buy	Common Stock C-Conversion	Ault Milton C Iii Director	Director	100 000 Value: $232.0K
Oct 03, 2025 Sell	Common Stock S-Sale	Ault Milton C Iii Director	Director	65 903 Value: $160.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ALZAMEND NEURO, INC.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative diseases and psychiatric disorders. Its pipeline includes AL001, an ionic cocrystal technology delivering a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's and other neurodegenerative diseases, and psychiatric disorders; and AL002, a method using a mutan...

Read Full Profile Here